Scott Glaser, M.D.
Chief of Brachytherapy and Gynecological Radiotherapy
4.9 (265 RATINGS)
Clinical Expertise
High-Dose Rate Brachytherapy
Stereotactic Radiosurgery
Intensity Modulated Radiation Therapy
Gynecological Cancer
Breast Cancer
Prostate Cancer
Appointments
Associate Professor, Department of Radiation Oncology
Clinical Teams
Breast Cancer
Cervical Cancer
Radiation Oncology
Gynecologic Cancers
Uterine and Endometrial Cancers
Scott Glaser, M.D., is an associate professor of radiation oncology at City of Hope. He specializes in high-dose rate brachytherapy, stereotactic radiosurgery and intensity modulated radiation therapy. His particular areas of interest include gynecological, breast and prostate cancers.
Dr. Glaser received an undergraduate degree from Hope College in Holland, Michigan, and a medical degree from the Loyola University Stritch School of Medicine in Chicago. He completed a medical internship at University of Nevada Reno, followed by a residency in radiation oncology at the University of Pittsburgh.
Dr. Glaser is a member of numerous professional organizations, including American Society for Radiation Oncology, American College of Radiation Oncology, American Society of Clinical Oncology and the American Brachytherapy Society. He has published over 70 manuscripts in peer-reviewed medical journals and is the recipient of numerous national and international awards related to this work. He serves on the NRG Oncology Core Committee for Cervical Cancer, working to develop multimodality clinical trials for gynecological cancers. At City of Hope, Dr. Glaser is the principal investigator on studies looking to optimize the treatment for breast, prostate, and gynecological cancers. He is on the editorial board of the journal Brachytherapy, and serves as a reviewer for multiple scientific journals. Dr. Glaser has been selected as one of the top doctors in Los Angeles each year since 2019 by Los Angeles Magazine.
Dr. Glaser received an undergraduate degree from Hope College in Holland, Michigan, and a medical degree from the Loyola University Stritch School of Medicine in Chicago. He completed a medical internship at University of Nevada Reno, followed by a residency in radiation oncology at the University of Pittsburgh.
Dr. Glaser is a member of numerous professional organizations, including American Society for Radiation Oncology, American College of Radiation Oncology, American Society of Clinical Oncology and the American Brachytherapy Society. He has published over 70 manuscripts in peer-reviewed medical journals and is the recipient of numerous national and international awards related to this work. He serves on the NRG Oncology Core Committee for Cervical Cancer, working to develop multimodality clinical trials for gynecological cancers. At City of Hope, Dr. Glaser is the principal investigator on studies looking to optimize the treatment for breast, prostate, and gynecological cancers. He is on the editorial board of the journal Brachytherapy, and serves as a reviewer for multiple scientific journals. Dr. Glaser has been selected as one of the top doctors in Los Angeles each year since 2019 by Los Angeles Magazine.
Duarte - Main Campus
1500 East Duarte Road
Duarte, CA 91010
Duarte, CA 91010
2012, M.D., With "Honors in Research", Loyola University Chicago, Stritch School of Medicine, Chicago, IL
2008, B.S., Chemistry, B.A., Psychology, summa cum laude, Hope College, Holland, MI
2013-2017, Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
2012-2013, Internal Medicine, University of Nevada Reno, Reno, NV
2017-present, Associate Professor, Department of Radiation Oncology, City of Hope, Duarte, CA
The Radiosurgery Society
American Society of Therapeutic Radiology and Oncology
American Brachytherapy Society
American College of Radiation Oncology
European Society for Therapeutic Radiology and Oncology
- Rodriguez-Lopez J, Patel A, Balasubramani G, Glaser S, Beriwal S, Vargo J. Treatment Selection and Survival Outcomes in Early-Stage Peripheral T-Cell Lymphomas: Does Anaplastic Lymphoma Kinase Mutation Impact the Benefit of Consolidative Radiotherapy? Leuk Lymphoma. 2020. In press.
- Rodriguez-Lopez J, Ling D, Keller A, Kim H, Mojica-Marquez A, Glaser S, Beriwal S. Ureteral Stenosis after 3D MRI-based Brachytherapy for Cervical Cancer – Have We Identified All the Risk Factors? Radiother Oncol. 2020. Epub ahead of print.
- Novak J, Cui Y, Frankel P, Sedrak M, Glaser S, Li R, Motwani S, Kavanagh B, Amini A. Growth of the Social #RadOnc Network on Twitter. Pract Radiat Oncol. 2020. In press.
- Wang E, Wei C, Liu S, Lee S, Shehayeb S, Glaser S, Li R, Saadat S, Shen J, Dellinger T, Han E, Stewart D, Wilczynski S, Cristea M, Rodriguez L. Frontline Management of Epithelial Ovarian Cancer – Combining Clinical Expertise with Community Practice Collaboration and Cutting-Edge Research. J Clin Med. 2020. In press.
- Li R, Germino E, Horne Z, Vargo J, Chen Y, Glaser S. External beam radiation and brachytherapy boost at different facilities is associated with increased treatment delays in cervical cancer. Int J Gynecol Cancer. 2020. epub ahead of print. PMID 32928924
- Li R, Shinde A, Liu A, Glaser S, Lyou Y, Wong J, Amini A. Machine learning-based interpretation and visualization of nonlinear interactions in prostate cancer survival. JCO Clin Cancer Inform. 2020 In press.
- Li R, Yashar C, Thaker N, Beriwal S, Glaser S. Radiation Oncology APM: an introduction and primer for the proposed rule for practices and providers. Pract Radiat Oncolo. 2020 epub ahead of print.
- Schad M, Patel A, Glaser S, Balasubramani G, Showalter T, Beriwal S, Vargo J. Declining Brachytherapy Utilization for Cervical Cancer Patients – Have We Reversed the Trend? Gyn Oncol. 2020;156:583-590.
- Horne Z, Wegner R, Colonias A, Weksler B, Glaser S, Kalash R, Beriwal S. Drivers of 30-/90-day post-op mortality following neoadjuvant chemoradiation for esophageal cancer. Ann Thorac Surg. 2020 epub ahead of print.
- Li R, Vazquez J, Chau B, Novak J, Dale W, Chen Y, Sedrak M, Warner S, Glaser S, Amini A. Patterns of care and treatment outcomes in patients age 80 or older with non-metastatic pancreatic cancer. J Geriatr Oncol. 2020;11:652-659.
- Shinde A, Li R, Amini A, Vapiwala N, Orio P, Vargo J, Chen Y, Beriwal S, Glaser S. Resident Experience in Brachytherapy: An Analysis of ACGME Case Logs for Intracavitary and Interstitial Brachytherapy from 2007-2018. Brachytherapy. 2019 epub ahead of print. PMID 31839568.
- Amini A, Li R, Shinde A, Nelson R, Sampath S, Vora N, Kang R, Gernon T, Maghami E, Hurria A, Massarelli E, Glaser S. Factors Predicting for Patient Refusal of Head and Neck Cancer Therapy. Head Neck. 2020;42:33-42. PMID 31584746
- Li R, Shinde A, Novak J, Vapiwala N, Amini A, Beriwal S, Chen Y, Glaser S. Temporal trends of resident experience in external beam radiation therapy cases: analysis of ACGME case logs from 2007-2018. Int J Radiat Oncol Biol Phys. 2020;106:37-42. PMID 31229573
- Shinde A, Verma V, Li R, Glaser S, Raoof M, Warner S, Chung V, Singh G, Chen Y, Goodman K, Amini A. The role of sequential radiation following adjuvant chemotherapy in resected pancreatic cancer. J Gastrointest Oncol. 2019;10:462-473.
- Shinde A, Verma V, Jones BL, Li R, Glaser S, Freeman M, Melstrom L, Kang R, Parvathaneni U, Modi B, Amini A. The Effect of Time to Postoperative Radiation Therapy on Survival in Resected Merkel Cell Carcinoma. Am J Clin Oncol 2019;42:636-642.
- Shinde A, Horne Z, Li R, Glaser S, Massarelli E, Koczywas M, Erhunmwunsee L, Reckamp K, Weksler B, Salgia R, Beriwal S, Amini A. Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio. Lung Cancer. 2019;133:136-143.
- Li R, Shinde A, Han E, Lee S, Beriwal S, Harkenrider M, Kamrava M, Chen YJ, Glaser S. Assessment of risk criteria for adjuvant therapy in stage I endometrial cancer. International Journal of Gynecologic Cancer. Int J Gynecol Cancer. 2019;29:1086-1093. PMID 31474587
- Mulherkar R, Hasan S, Wegner R, Verma V, Glaser S, Kalash R, Beriwal S, Horne Z. National patterns of care for early-stage penile cancers in the United States: How is radiation and brachytherapy utilized? Brachytherapy 2019; 18:503-509.
- Li R, Shinde A, Fakih M, Sentovich S, Melstrom K, Nelson R, Glaser S, Chen Y, Goodman K, Amini A. Impact of surgical resection on survival outcomes after chemoradiation in anal adenocarcinoma. J Natl Compr Cancr Netw. 2019;17:1203-1210.
- Amini A, Verma V, Glaser S, Shinde S, Sampath S, Gaspar L Stokes W, Rusthoven C, Massarelli E, Salgia R, Liu A. Early Mortality of Stage IV Non-Small Cell Lung Cancer in the United States. Acta Oncol 2019;58:1095-1101.
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
Ratings
5.0
Show respect for what you say
5.0
Spend enough time with you
5.0
Recommend this provider office
4.9
Know important info medical history
4.9
Rate provider 0-10
4.9
Provider explain in way you understand
4.9
Provider listen carefully to you
Reviews
08/13/23
I continue to be impressed by the Rad Onc team. My appts are always early/on time and each member of the team is kind, caring and attentive. - Verified patient
07/22/23
Excellent - Verified patient
07/22/23
Excellent - Verified patient
06/22/23
Dr Glaser has great verbal skills. Treatment was far better than the videos of the procedure. - Verified patient
06/21/23
I love city of hope. If anyone I know or love has cancer, coh will be the first hospital I will recommend. From the appointment receptionists on the phone to everyone I encounter including my doctor or np, everyone is accommodating, courteous and caring. I have been a patient since [...] and every visit I had, I have nothing but compliments to everyone at coh. [...] - Verified patient